| Financial Year |
March 31 2023 |
| Monetary Funds |
925,051,979.89 |
| Held-for-trading Financial Assets |
568,180,377.95 |
| Notes Receivable |
8,179,384.90 |
| Accounts Receivable |
221,484,258.85 |
| Advances to Suppliers |
8,988,945.57 |
| Other Receivables |
8,274,892.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
261.16 |
| Dividend Receivable |
-- |
| Inventories |
218,074,980.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,808,221.38 |
| Total Current Assets |
1,976,043,042.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
252,224.16 |
| Investment Properties |
4,948,117.50 |
| Fixed Assetes |
649,827,271.82 |
| Under-construction Projects |
81,686,353.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
282,807,892.60 |
| R&D expenses |
-- |
| Goodwill |
36,673,724.02 |
| Long-Term Deferred and Prepaid Expenses |
9,272,594.59 |
| Deferred Income Tax Assets |
17,183,859.01 |
| Other Non-Current Assets |
55,251,168.24 |
| Sub-Total of Non-Current Assets |
1,148,252,031.86 |
| Total Assets |
3,124,295,074.02 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
62,840,637.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,138,403.32 |
| Taxes Payable |
2,835,461.49 |
| Interest Payable |
267,596.13 |
| Dividend Payable |
4,142,992.62 |
| Other payables |
40,006,304.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
208,123.95 |
| Other Current Liabilities |
84,723.35 |
| Sub-Total of Current Liabilities |
217,945,347.67 |
| Long-term Loans |
-- |
| Bonds Payable |
51,615,321.37 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,100,717.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
107,685,787.17 |
| Total Liabilities |
325,631,134.84 |
| Paid-In Capital(Or Share Stock) |
490,081,254.00 |
| Capital Surplus |
1,616,341,807.95 |
| Surplus Reserve |
94,120,936.48 |
| LESS:Treasury Stock |
69,104,928.45 |
| Undistributed Profits |
545,933,012.78 |
| Minority Stockholder's Interest |
111,196,781.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,687,467,157.71 |
| Owner's Equity（Stockholder's Equity） |
2,798,663,939.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,124,295,074.02 |
